The molecular mechanisms that contribute to sex differences, in particular female predominance, in Alzheimer’s disease (AD) prevalence, symptomology, and pathology, are incompletely understood.
The molecular mechanisms that contribute to sex differences, in particular female predominance, in Alzheimer’s disease (AD) prevalence, symptomology, and pathology, are incompletely understood.